Details for New Drug Application (NDA): 077440
✉ Email this page to a colleague
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 077440
| Tradename: | POTASSIUM CITRATE |
| Applicant: | Rising |
| Ingredient: | potassium citrate |
| Patents: | 0 |
Pharmacology for NDA: 077440
| Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for 077440
Suppliers and Packaging for NDA: 077440
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 077440 | ANDA | Rising Pharma Holdings, Inc. | 16571-864 | 16571-864-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-864-01) |
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 077440 | ANDA | Rising Pharma Holdings, Inc. | 16571-865 | 16571-865-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-865-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MEQ | ||||
| Approval Date: | Jun 9, 2006 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
| Approval Date: | Jun 9, 2006 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
